SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549


                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934


         Date of Report (date of earliest event reported): June 12, 2002


                               THERMOGENESIS CORP.
             (Exact name of registrant as specified in its charter)



           Delaware                      0-16375                 94-3018487
           --------                      -------                 ----------
(State or other jurisdiction of  (Commission File Number)     (I.R.S. Employer
 incorporation or organization)                              Identification No.)

                              3146 Gold Camp Drive
                        Rancho Cordova, California 95670
                                 (916) 858-5100
          (Address and telephone number of principal executive offices)



<PAGE>


ITEM 5.  OTHER EVENTS AND REGULATION FD DISCLOSURE

     On June  12,  2002,  ThermoGenesis  Corp.  ("ThermoGenesis")  accepted  the
resignation of James Godsey, Ph.D., as President, Chief Operating Officer and as
a member of the Board of  Directors.  Dr.  Godsey  served as President and Chief
Operating  Officer since  November 1997 and as a Director since 1998. Dr. Godsey
will remain with ThermoGenesis through the beginning of July 2002 to assist with
the transition.  ThermoGenesis is interviewing candidates for his prior position
and anticipates filing the position in the future. Until the position is filled,
Philip H. Coelho,  ThermoGenesis'  Chairman and Chief  Executive  Officer,  will
resume  direction of day-to-day  operations.  Renee  Ruecker,  Vice President of
Finance, Sam Acosta, Vice President Manufacturing Operations and Dan Segal, V.P.
Sales and Marketing will report directly to the Chief Executive  Officer until a
new President and Chief Operating Officer is appointed.

ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS

     (c) EXHIBITS

         Exhibit
         Number            Description
         -------           -----------

         99                Press Release Announcing Resignation



<PAGE>


                                    SIGNATURE

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


Dated:  June 17, 2002                        THERMOGENESIS CORP.


                                             /S/ PHILIP H. COELHO
                                             ------------------------------
                                             Philip H. Coelho,
                                             Chairman & Chief Executive Officer


<PAGE>
                                   Exhibit 99

           THERMOGENESIS CORP. Announces Executive Management Changes.

Rancho Cordova,  Calif.  (June 17, 2002) - THERMOGENESIS  CORP.  (Nasdaq:  KOOL)
today  announced that James Godsey,  Ph.D. has resigned from the Company to join
Gen-Probe,  a leading  manufacturer  of molecular  diagnostics.  Dr. Godsey will
remain with the Company  through the  beginning  of July 2002,  to help ensure a
smooth  transition with his predecessor.  The Company is currently  interviewing
several  candidates  and  anticipates  having  one in place in the near  future.
Philip H. Coelho,  THERMOGENESIS'  Chairman and Chief  Executive  Officer,  will
resume direction of day-to-day operations of the Company.

"We would  like to thank Dr.  Godsey  for his  service  with the  Company as its
President,  and his  overall  efforts on the Board of  Directors,"  said  Philip
Coelho,  Chairman and CEO of  THERMOGENESIS.  "Our management team over the past
five  years  has  developed  and  implemented  an  internal  structure  that has
demonstrated  solid  performance  and  improvement  as we move from a late stage
Research and Development firm, to a revenue generating  operating  company." Mr.
Coelho concluded,  "I am encouraged that we will continue to grow the Company to
the next level with the excellent talent of our executive team."

The Company  earlier  announced the  appointment of Edward Cape,  Ph.D.,  who is
serving a one-year  term as Executive  Vice  President  of  Corporate  Strategy,
reporting  directly to the  Company's  Chairman and CEO. Cape is on the Board of
Directors of the Company.  Also  reporting to Coelho  following  the  management
changes will be Renee Ruecker,  the Company's V.P. of Finance,  Sam Acosta, V.P.
Manufacturing Operations, and Dan Segal, V.P. Sales and Marketing.

About THERMOGENESIS CORP.
ThermoGenesis  Corp. has been a pioneer in designing and  manufacturing  medical
devices, and designing sterile disposable bag sets to collect,  cryopreserve and
archive blood products such as stem cells from cord blood, blood plasma,  fibrin
sealant  and  other  related  blood  products.   After  extensive  research  and
development,  two new  technology  platforms (the  BioArchive(R)  System and the
CryoSeal(R)  System)  have  evolved  products,  which  provide new  bio-material
products to patients in need.

The  statements  contained in this release  which are not  historical  facts are
forward-looking  statements  that are  subject to risks and  uncertainties  that
could cause  actual  results to differ  materially  from those  expressed in the
forward-looking statements, including, but not limited to, certain delays beyond
the company's  control with respect to market acceptance of new technologies and
products, delays in testing and evaluation of products, and other risks detailed
from time to time in the  Company's  filings  with the  Securities  and Exchange
Commission.

                         For More Information, Contact:

                               THERMOGENESIS CORP.
           Philip H. Coelho: pcoelho@thermogenesis.com (916) 858-5100

                                    MKR Group
             Charles Messman: cmessman@mkr-group.com, (212) 308-4557
               Todd Kehrli: tkehrli@mkr-group.com, (310) 314-3800

                 or visit the web site at www.thermogenesis.com
                                       ###
[{"type": "8-K", "sequence": "1", "filename": "for061202.txt", "description": "FOR 061202", "secsgml_size_bytes": 6333}]
{"company-data": {"conformed-name": "THERMOGENESIS CORP", "cik": "0000811212", "assigned-sic": "3821", "irs-number": "943018487", "state-of-incorporation": "DE", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-82900", "film-number": "02680977"}, "business-address": {"street1": "3146 GOLD CAMP DRIVE", "city": "RANCHO CORDOVA", "state": "CA", "zip": "95670", "phone": "9168585100"}, "mail-address": {"street1": "3146 GOLD CAMP DRIVE", "city": "RANCHO CORDOVA", "state": "CA", "zip": "95670"}, "former-company": {"former-conformed-name": "INSTA COOL INC OF NORTH AMERICA", "date-changed": "19920703"}}
SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K

                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

         Date of Report (date of earliest event reported): June 12, 2002

                               THERMOGENESIS CORP.
             (Exact name of registrant as specified in its charter)

           Delaware                      0-16375                 94-3018487
           --------                      -------                 ----------
(State or other jurisdiction of  (Commission File Number)     (I.R.S. Employer
 incorporation or organization)                              Identification No.)

                              3146 Gold Camp Drive
                        Rancho Cordova, California 95670
                                 (916) 858-5100
          (Address and telephone number of principal executive offices)
ITEM 5.  OTHER EVENTS AND REGULATION FD DISCLOSURE

     On June  12,  2002,  ThermoGenesis  Corp.  ("ThermoGenesis")  accepted  the
resignation of James Godsey, Ph.D., as President, Chief Operating Officer and as
a member of the Board of  Directors.  Dr.  Godsey  served as President and Chief
Operating  Officer since  November 1997 and as a Director since 1998. Dr. Godsey
will remain with ThermoGenesis through the beginning of July 2002 to assist with
the transition.  ThermoGenesis is interviewing candidates for his prior position
and anticipates filing the position in the future. Until the position is filled,
Philip H. Coelho,  ThermoGenesis'  Chairman and Chief  Executive  Officer,  will
resume  direction of day-to-day  operations.  Renee  Ruecker,  Vice President of
Finance, Sam Acosta, Vice President Manufacturing Operations and Dan Segal, V.P.
Sales and Marketing will report directly to the Chief Executive  Officer until a
new President and Chief Operating Officer is appointed.

ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS

     (c) EXHIBITS

         Exhibit
         Number            Description
         -------           -----------

         99                Press Release Announcing Resignation
SIGNATURE

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Dated:  June 17, 2002                        THERMOGENESIS CORP.

                                             /S/ PHILIP H. COELHO
                                             ------------------------------
                                             Philip H. Coelho,
                                             Chairman & Chief Executive Officer
Exhibit 99

           THERMOGENESIS CORP. Announces Executive Management Changes.

Rancho Cordova,  Calif.  (June 17, 2002) - THERMOGENESIS  CORP.  (Nasdaq:  KOOL)
today  announced that James Godsey,  Ph.D. has resigned from the Company to join
Gen-Probe,  a leading  manufacturer  of molecular  diagnostics.  Dr. Godsey will
remain with the Company  through the  beginning  of July 2002,  to help ensure a
smooth  transition with his predecessor.  The Company is currently  interviewing
several  candidates  and  anticipates  having  one in place in the near  future.
Philip H. Coelho,  THERMOGENESIS'  Chairman and Chief  Executive  Officer,  will
resume direction of day-to-day operations of the Company.

"We would  like to thank Dr.  Godsey  for his  service  with the  Company as its
President,  and his  overall  efforts on the Board of  Directors,"  said  Philip
Coelho,  Chairman and CEO of  THERMOGENESIS.  "Our management team over the past
five  years  has  developed  and  implemented  an  internal  structure  that has
demonstrated  solid  performance  and  improvement  as we move from a late stage
Research and Development firm, to a revenue generating  operating  company." Mr.
Coelho concluded,  "I am encouraged that we will continue to grow the Company to
the next level with the excellent talent of our executive team."

The Company  earlier  announced the  appointment of Edward Cape,  Ph.D.,  who is
serving a one-year  term as Executive  Vice  President  of  Corporate  Strategy,
reporting  directly to the  Company's  Chairman and CEO. Cape is on the Board of
Directors of the Company.  Also  reporting to Coelho  following  the  management
changes will be Renee Ruecker,  the Company's V.P. of Finance,  Sam Acosta, V.P.
Manufacturing Operations, and Dan Segal, V.P. Sales and Marketing.

About THERMOGENESIS CORP.
ThermoGenesis  Corp. has been a pioneer in designing and  manufacturing  medical
devices, and designing sterile disposable bag sets to collect,  cryopreserve and
archive blood products such as stem cells from cord blood, blood plasma,  fibrin
sealant  and  other  related  blood  products.   After  extensive  research  and
development,  two new  technology  platforms (the  BioArchive(R)  System and the
CryoSeal(R)  System)  have  evolved  products,  which  provide new  bio-material
products to patients in need.

The  statements  contained in this release  which are not  historical  facts are
forward-looking  statements  that are  subject to risks and  uncertainties  that
could cause  actual  results to differ  materially  from those  expressed in the
forward-looking statements, including, but not limited to, certain delays beyond
the company's  control with respect to market acceptance of new technologies and
products, delays in testing and evaluation of products, and other risks detailed
from time to time in the  Company's  filings  with the  Securities  and Exchange
Commission.

                         For More Information, Contact:

                               THERMOGENESIS CORP.
           Philip H. Coelho: pcoelho@thermogenesis.com (916) 858-5100

                                    MKR Group
             Charles Messman: cmessman@mkr-group.com, (212) 308-4557
               Todd Kehrli: tkehrli@mkr-group.com, (310) 314-3800

                 or visit the web site at www.thermogenesis.com
                                       ###